Yagai Tomoki, Matsui Satoshi, Harada Kenichi, Inagaki Fuyuki F, Saijou Eiko, Miura Yasushi, Nakanuma Yasuni, Miyajima Atsushi, Tanaka Minoru
Laboratory of Cell Growth and Differentiation, Institute of Molecular and Cellular Biosciences, The University of Tokyo, Tokyo, Japan.
Department of Regenerative Medicine, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.
PLoS One. 2017 Apr 7;12(4):e0175355. doi: 10.1371/journal.pone.0175355. eCollection 2017.
Cholangiocarcinoma (CC) is a type of relatively rare neoplasm in adenocarcinoma. The characteristics of CCs as well as biliary epithelial cells are heterogeneous at the different portion of the biliary tree. There are two candidate stem/progenitor cells of the biliary tree, i.e., biliary tree stem/progenitor cell (BTSC) at the peribiliary gland (PBG) of large bile ducts and liver stem/progenitor cell (LPC) at the canals of Hering of peripheral small bile duct. Although previous reports suggest that intrahepatic CC (ICC) can arise from such stem/progenitor cells, the characteristic difference between BTSC and LPC in pathological process needs further investigation, and the etiology of CC remains poorly understood. Here we show that Sterile alpha motif domain containing 5 (SAMD5) is exclusively expressed in PBGs of large bile ducts in normal mice. Using a mouse model of cholestatic liver disease, we demonstrated that SAMD5 expression was upregulated in the large bile duct at the hepatic hilum, the extrahepatic bile duct and PBGs, but not in proliferating intrahepatic ductules, suggesting that SAMD5 is expressed in BTSC but not LPC. Intriguingly, human ICCs and extrahepatic CCs exhibited striking nuclear localization of SAMD5 while the normal hilar large bile duct displayed slight-to-moderate expression in cytoplasm. In vitro experiments using siRNA for SAMD5 revealed that SAMD5 expression was associated with the cell cycle regulation of CC cell lines.
SAMD5 is a novel marker for PBG but not LPC in mice. In humans, the expression and location of SAMD5 could become a promising diagnostic marker for the cell type as well as malignancy of bile ducts and CCs.
胆管癌(CC)是腺癌中一种相对罕见的肿瘤类型。胆管癌以及胆管上皮细胞在胆管树的不同部位具有异质性。胆管树有两种候选干/祖细胞,即大胆管胆管周围腺(PBG)处的胆管树干/祖细胞(BTSC)和外周小胆管赫林管处的肝干/祖细胞(LPC)。尽管先前的报道表明肝内胆管癌(ICC)可起源于此类干/祖细胞,但BTSC和LPC在病理过程中的特征差异仍需进一步研究,且胆管癌的病因仍知之甚少。在此我们表明,含无菌α基序结构域5(SAMD5)在正常小鼠的大胆管PBG中特异性表达。利用胆汁淤积性肝病小鼠模型,我们证明SAMD5在肝门部大胆管、肝外胆管和PBG中表达上调,但在增殖的肝内小胆管中不表达,这表明SAMD5在BTSC而非LPC中表达。有趣的是,人ICC和肝外CC显示出SAMD5显著的核定位,而正常肝门部大胆管在细胞质中呈轻度至中度表达。使用针对SAMD5的小干扰RNA进行的体外实验表明,SAMD5表达与CC细胞系的细胞周期调控相关。
SAMD5是小鼠中PBG而非LPC的新型标志物。在人类中,SAMD5的表达和定位可能成为胆管和CC细胞类型及恶性程度的有前景的诊断标志物。